Analyzing Clinical Trial Experiences of Prostate Cancer Patients

NCT05411354 · tracked via the Priya Life Science USA tracker

Sponsor

Power Life Sciences Inc

Phase

Observational

Started

2024-09

Last updated

2024-01-02

Condition(s) studied

Prostate Cancer

Study summary

Participation in clinical trials usually favors a particular demographic group. But there is limited research available to explain what trial attributes affect the participation or completion of these specific demographic groups.

This study will admit a wide range of data on the clinical trial experience of Prostate Cancer patients to determine which factors prevail in limiting a patient's ability to join or finish a trial.

It will also try to analyze data from the perspective of different demographic groups to check for recurring trends which might shed insights for the sake of future Prostate Cancer patients.

Eligibility

Sex

MALE

Min age

18 Years

Max age

—

Healthy volunteers

Inclusion Criteria: * Patient has been diagnosed with Prostate Cancer as identified by imaging * Patient has self-identified as planning to enroll in an interventional clinical trial for Prostate Cancer * Patient is at least 18 years of age Exclusion Criteria: * Patient does not understand, sign, and return consent form * Inability to perform regular electronic reporting * Patient has a ECOG score of 4

Primary outcome measure(s)

Rate of patients who decide to enroll in a Prostate Cancer Clinical Trial — 3 months
Number of patients who remain in Prostate Cancer clinical trial until completion of clinical trial — 12 months

Trial sites (1)

Facility	City	Region	Status
Power Life Sciences	San Francisco	California

More Power Life Sciences Inc. trials in the USA

Revealing Engagement Patterns Among Endometrial Cancer Patients Starting soon

A Detailed Look At What Patients Experience In Medullary Thyroid Cancer Clinical Study Starting soon

Examining Engagement Trends Among Participants in Peripheral Neuropathy Clinical Research Starting soon

Studying Patterns in Patient Engagement Among Treatment Resistant Depression Patients Starting soon

Navigating the Clinical Research Process for Lymphoma Starting soon

Other trials for the same condition

A Trial to Learn How Safe AZD9750 is and How Well it Works in People With Metastatic Prostate Cancer When Given With or Without Other Anticancer Drugs Recruiting

Continued Access of Focal MR-Guided Focused Ultrasound for Localized Intermediate Risk Prostate Lesions Active, not recruiting

Safety and Efficacy Study of Enzalutamide Plus Leuprolide in Patients With Nonmetastatic Prostate Cancer (EMBARK) Active, not recruiting

Randomized Controlled Trial of CAN-2409 Immunotherapy During Active Surveillance for Prostate Cancer (ULYSSES) Active, not recruiting

Effectiveness of the SpaceOAR Vue System in Subjects With Prostate Cancer Active, not recruiting

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05411354 on ClinicalTrials.gov ↗ ← All trials in the USA